(Q36466103)

14 August 2017

1 reference

title

hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis (English)

1 reference

14 August 2017

hu-PBL-SCID Mice: A Model for Human Immune Function, AIDS, and Lymphomagenesis (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

24 October 2022

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666627

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

24 October 2022

1 reference

B. E. Torbett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666627

24 October 2022

G. Picchio

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666627

24 October 2022

D. E. Mosier

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666627

24 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1666627

24 October 2022

publication date

1 December 1991

1 reference

full work available at URL

14 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1991.tb00620.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-065X.1991.tb00620.x/fullpdf

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

24 October 2022

published in

Immunological Reviews

1 reference

14 August 2017

volume

124

1 reference

14 August 2017

page(s)

139-164

1 reference

Cellular basis of the proliferative response of human T cells to mouse xenoantigens

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

A severe combined immunodeficiency mutation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Evidence of functional lymphocytes in some (leaky) scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Animal models for antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Genetic and cellular aspects of xenogeneic mixed leukocyte culture reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Long-term human hematopoiesis in the SCID-hu mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Xenogeneic human anti-mouse T cell responses are due to the activity of the same functional T cell subsets responsible for allospecific and major histocompatibility complex-restricted responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Human, rat or mouse hybridomas secrete high levels of monoclonal antibodies following transplantation into mice with severe combined immunodeficiency disease (SCID).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Transfer of a functional human immune system to mice with severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Interleukin-4 mediates CDS induction on human CD4+ T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Growth of human tumors in immune-deficient scid mice and nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1991.TB00620.X

Human lung tumors, patients' peripheral blood lymphocytes and tumor infiltrating lymphocytes propagated in scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Animal models for acquired immunodeficiency syndrome

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Cytological Identification of Radiation-Chimæras

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS)

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Engraftment of immune-deficient mice with human hematopoietic stem cells

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Engraftment and Development of Human T and B Cells in Mice After Bone Marrow Transplantation

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Obtention of a human primary humoral response against schistosome protective antigens in severe combined immunodeficiency mice after the transfer of human peripheral blood mononuclear cells

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS.

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Human immunodeficiency virus infection of human-PBL-SCID mice

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Natural killer cells activated with interleukin 2 in vitro can be adoptively transferred and mediate hematopoietic histocompatibility-1 antigen-specific bone marrow rejection in vivo

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Tumorigenicity of human hematopoietic cell lines in athymic nude mice

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

The immunopathogenesis of HIV infection

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell l

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

24 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1991.TB00620.X

24 October 2022

Identifiers

1 reference

14 August 2017

1 reference